EDN1 and Alzheimer disease: In particular, the mean ET-1 level in patients with AD-ILD and IPF was 1.44 ± 0.81 pg/mL and 1.35 ± 0.46 pg/mL, respectively, whereas in controls it was 0.86 ± 0.35 pg/mL.